Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: JW THERAP-B(02126) the Revenue is 64.26 M (+10.41%);the EBIT is -53.64 M (+14.05%);the EPS is -0.0698 (+80.15%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.06B10.41%
----
----
EBIT
-0.05B14.05%
----
----
EPS
-0.069880.15%
----
----
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf